Data from animal models might not be especially useful in this regard unless models that permit viral replication are available. Further, attention to the selection of lesions that are most suitable for injection is necessary and the inclusion of appropriate eligibility and exclusion criteria based on the underlying pathogenicity and immunogenicity of the specific virus should be considered.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.13M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $236.6K | 21.49M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 9419727 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 12350743 | 51 |
View Market Depth
| Last trade - 13.19pm 26/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |